Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial update evaluating the sequencing of pembrolizumab alone or with chemotherapy as first-line therapy and maintenance in non-smal…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Clinical Trial of TB511 in Advanced Solid Tumors [Phase 1, Phase 2]
This update covers an early-phase trial of TB511 in advanced solid tumors, including non-small cell lung cancer and prostate cancer, with co…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)
Clinical trial update describing a study on long-term responders in metastatic lung cancer to improve management, currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial update testing Telaglenastat and Sapanisertib in advanced non-small cell lung cancer with brain and leptomeningeal me…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: DRP-104 in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study of DRP-104 in patients with NFE2L2/KEAP1-altered non-small cell lung cancer is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies [NA]
Clinical trial update on real-time symptom monitoring in lung cancer patients receiving oral targeted therapies, including EGFR-mutant and o…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC [Phase 1]
Phase 1 trial evaluating LB-LR1109 alone and in combination with atezolizumab for solid tumors, including non-small cell lung cancer, curren…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis
This clinical trial update describes a flow cytometry-based neutrophil biomarker test intended to predict clinical benefit from immunotherap…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating CLN-619 alone and in combination with pembrolizumab in advanced solid tumors, including non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Is 3D Modeling From Non-contrast CT Accurate for Minimally Invasive Lung Segmentectomies ?
An updated clinical trial from University Hospital, Strasbourg evaluates whether three-dimensional modeling derived from non-contrast CT sca…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors [Phase 1]
This clinical trial update reports a Phase 1 study of BL-M24D1 in locally advanced or metastatic non-small cell lung cancer and other solid …
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Patient-centered, Optimal Integration of Survivorship and Palliative Care [NA]
A Massachusetts General Hospital trial is recruiting to evaluate patient-centered integration of survivorship and palliative care for patien…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Study of GV20-0251 in Advanced or Refractory Solid Tumors [Phase 1]
This Phase 1 clinical trial update indicates that GV20-0251 is being studied in advanced or refractory solid tumors and is currently recruit…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3) [Phase 3]
Phase 3 TRIDENT-3 trial comparing repotrectinib versus crizotinib in treatment-naïve ROS1-positive non-small cell lung cancer; the study is …
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for HiFiBiO's HFB200301 as a single agent and in combination with tislelizumab in adults with advanc…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of HFB200603 as a single agent and in combination with tislelizumab in adults with advanced solid tumors, including renal cell…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC [Phase 3]
Phase 3 trial comparing JMKX001899 to docetaxel in previously treated KRAS G12C-mutant non-small cell lung cancer is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Ivonescimab Monotherapy or in Combination With Chemotherapy as Neoadjuvant/Adjuvant Therapy for Resectable Non-small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating Ivonescimab as a standalone treatment or with chemotherapy as neoadjuvant/adjuvant therapy for resectable non-small…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Generation of Reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines
A registry entry describing a trial testing a tumor whole cell antigen nanovaccine to generate reactive T cells for non-small cell lung canc…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma [Phase 2]
Phase 2 study of LP-300 with carboplatin and pemetrexed in never-smokers with advanced lung adenocarcinoma; trial currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: To Evaluate the Efficacy and Safety of Anlotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of Anlotinib hydrochloride capsule in postoperative non-pCR patients with non-smal…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC [NA]
Ongoing clinical trial evaluating electroacupuncture combined with a PD-1 inhibitor for advanced non-small cell lung cancer in patients with…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality [Phase 2]
A Phase 2 clinical trial evaluating TQB2102 for injection in non-small cell lung cancer with HER2 gene abnormalities is currently recruiting…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Expanded Access Use of Cemiplimab in Patients With Solid Tumors
Expanded access update on cemiplimab for patients with solid tumors, including non-small cell lung cancer, basal cell carcinoma, and cutaneo…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Cognition and Patients With Lung Cancer
This ClinicalTrials.gov update describes a study evaluating cognition in patients with localized, operable non-small cell lung cancer; the t…